DETERMAVU Trademark

Trademark Overview

On Tuesday, May 9, 2017, a trademark application was filed for DETERMAVU with the United States Patent and Trademark Office. The USPTO has given the DETERMAVU trademark a serial number of 87443294. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, December 28, 2020. This trademark is owned by OncoCyte Corporation. The DETERMAVU trademark is filed in the Medical Instrument Products and Medical & Beauty Services & Agricultural Services categories with the following description:

Liquid biopsy tests and devices, namely, medical instruments for use in performing biopsies and medical diagnostic apparatus for testing biomarkers; cancer screening tests and devices, namely, medical devices for detecting cancer; blood testing apparatus for cancer diagnosis; medical testing devices for tumor diagnosis

Medical testing for diagnostic or treatment purposes; medical testing for diagnostic or treatment purposes in the field of cancer; liquid biopsy testing for medical purposes for diagnostic or treatment purposes; liquid biopsy testing in the nature of medical testing for diagnostic or treatment purposes in the field of cancer
determavu

General Information

Serial Number87443294
Word MarkDETERMAVU
Filing DateTuesday, May 9, 2017
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, December 28, 2020
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, September 26, 2017

Trademark Statements

Goods and ServicesLiquid biopsy tests and devices, namely, medical instruments for use in performing biopsies and medical diagnostic apparatus for testing biomarkers; cancer screening tests and devices, namely, medical devices for detecting cancer; blood testing apparatus for cancer diagnosis; medical testing devices for tumor diagnosis
Goods and ServicesMedical testing for diagnostic or treatment purposes; medical testing for diagnostic or treatment purposes in the field of cancer; liquid biopsy testing for medical purposes for diagnostic or treatment purposes; liquid biopsy testing in the nature of medical testing for diagnostic or treatment purposes in the field of cancer

Classification Information

International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code6 - Active
Class Status DateSaturday, May 13, 2017
Primary Code010
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE
International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateSaturday, May 13, 2017
Primary Code044
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameOncoCyte Corporation
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressIrvine, CA 92618
Party NameOncoCyte Corporation
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressAlameda, CA 94501

Trademark Events

Event DateEvent Description
Monday, December 28, 2020ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, December 28, 2020ABANDONMENT - NO USE STATEMENT FILED
Wednesday, June 17, 2020APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, June 17, 2020TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, June 17, 2020TEAS CHANGE OF OWNER ADDRESS RECEIVED
Friday, May 22, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, May 21, 2020EXTENSION 5 GRANTED
Tuesday, May 19, 2020EXTENSION 5 FILED
Tuesday, May 19, 2020TEAS EXTENSION RECEIVED
Monday, May 18, 2020APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, May 18, 2020TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, May 18, 2020TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Monday, May 18, 2020ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, May 18, 2020TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, May 18, 2020TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, November 26, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, November 25, 2019EXTENSION 4 GRANTED
Thursday, November 21, 2019EXTENSION 4 FILED
Monday, November 25, 2019CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, November 21, 2019TEAS EXTENSION RECEIVED
Thursday, November 21, 2019ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, November 21, 2019TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, May 16, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, May 14, 2019EXTENSION 3 GRANTED
Tuesday, May 14, 2019EXTENSION 3 FILED
Tuesday, May 14, 2019TEAS EXTENSION RECEIVED
Tuesday, March 19, 2019TEAS CHANGE OF CORRESPONDENCE RECEIVED
Saturday, November 3, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, November 1, 2018EXTENSION 2 GRANTED
Thursday, November 1, 2018EXTENSION 2 FILED
Thursday, November 1, 2018TEAS EXTENSION RECEIVED
Wednesday, April 25, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, April 23, 2018EXTENSION 1 GRANTED
Monday, April 23, 2018EXTENSION 1 FILED
Monday, April 23, 2018TEAS EXTENSION RECEIVED
Tuesday, November 21, 2017NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, September 26, 2017OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, September 26, 2017PUBLISHED FOR OPPOSITION
Wednesday, September 6, 2017NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, August 18, 2017ASSIGNED TO LIE
Thursday, August 3, 2017APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, August 1, 2017EXAMINER'S AMENDMENT ENTERED
Tuesday, August 1, 2017NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Tuesday, August 1, 2017EXAMINERS AMENDMENT E-MAILED
Tuesday, August 1, 2017EXAMINERS AMENDMENT -WRITTEN
Wednesday, July 26, 2017ASSIGNED TO EXAMINER
Saturday, May 13, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Friday, May 12, 2017NEW APPLICATION ENTERED IN TRAM

Related Keywords

determavu medical testing cancer diagnostic purposes treatment devices biopsy liquid tests